Next Article in Journal
The Effects and Mechanisms of PBM Therapy in Accelerating Orthodontic Tooth Movement
Previous Article in Journal
Computational Analysis Reveals Unique Binding Patterns of Oxygenated and Deoxygenated Myoglobin to the Outer Mitochondrial Membrane
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential

1
Department of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China
2
The Second Clinical Medical College, Lanzhou University, Lanzhou 730030, China
3
Orthopaedics Key Laboratory of Gansu Province, Lanzhou University Second Hospital, Lanzhou 730030, China
4
School of Petrochemical Engineering, Lanzhou University of Technology, Lanzhou 730050, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Biomolecules 2023, 13(7), 1139; https://doi.org/10.3390/biom13071139
Submission received: 4 June 2023 / Revised: 11 July 2023 / Accepted: 14 July 2023 / Published: 17 July 2023

Abstract

S100A6, also known as calcyclin, is a low-molecular-weight Ca2+-binding protein from the S100 family that contains two EF-hands. S100A6 is expressed in a variety of mammalian cells and tissues. It is also expressed in lung, colorectal, pancreatic, and liver cancers, as well as other cancers such as melanoma. S100A6 has many molecular functions related to cell proliferation, the cell cycle, cell differentiation, and the cytoskeleton. It is not only involved in tumor invasion, proliferation, and migration, but also the pathogenesis of other non-neoplastic diseases. In this review, we focus on the molecular mechanisms and potential therapeutic targets of S100A6 in tumors, nervous system diseases, leukemia, endometriosis, cardiovascular disease, osteoarthritis, and other related diseases.
Keywords: S100A6; tumor; Alzheimer’s disease; leukemia; endometriosis; myocardial infarction S100A6; tumor; Alzheimer’s disease; leukemia; endometriosis; myocardial infarction

Share and Cite

MDPI and ACS Style

Yang, F.; Ma, J.; Zhu, D.; Wang, Z.; Li, Y.; He, X.; Zhang, G.; Kang, X. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. Biomolecules 2023, 13, 1139. https://doi.org/10.3390/biom13071139

AMA Style

Yang F, Ma J, Zhu D, Wang Z, Li Y, He X, Zhang G, Kang X. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. Biomolecules. 2023; 13(7):1139. https://doi.org/10.3390/biom13071139

Chicago/Turabian Style

Yang, Fengguang, Jinglin Ma, Daxue Zhu, Zhaoheng Wang, Yanhu Li, Xuegang He, Guangzhi Zhang, and Xuewen Kang. 2023. "The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential" Biomolecules 13, no. 7: 1139. https://doi.org/10.3390/biom13071139

APA Style

Yang, F., Ma, J., Zhu, D., Wang, Z., Li, Y., He, X., Zhang, G., & Kang, X. (2023). The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. Biomolecules, 13(7), 1139. https://doi.org/10.3390/biom13071139

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop